IL6 and neuromyelitis optica: Importantly, IL-6 correlates with various clinical parameters of NMO, such as the length of myelitis and disease severity scores, particularly in drug-naive patients, while it correlates with markers of glial damage, such as glial fibrillary acidic protein [63,64,65,66].